About Gls Pharma Limited
Data last updated: 11 January 2026
Gls Pharma Limited is a public limited company based in Seri Lingampally, Telangana, India, a subsidiary of Aurobindo Pharma Ltd. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 01 September 2004, the company has been in operation for over 22 years.
Registered with ROC Hyderabad under CIN U24239TS2004PLC184306.
Capital: an authorised share capital of ₹1.3 Cr and a paid-up capital of ₹1.2 Cr. Formerly known as Gls Pharma Private Limited and Getwell Life Sciences India Private Limited. It is led by directors including Srinivasa Ramachandra Rao Ilapakurthy and Pendem Harish Babu.
Last AGM: 22 September 2025. Financial statements filed for year ended 31 March 2025. Office: Seri Lingampally, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹36.08 Cr, reflecting significant growth compared to the previous year.
The company has a workforce of approximately 116 employees as per the latest available data. It operates as a subsidiary of Aurobindo Pharma Ltd.
The company is associated with 1 brand - Gls Pharma. As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹15.83 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website glspharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressGalaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1, Hyderabad Knowledge City Raidurg Panmaktha, Seri Lingampally, Telangana, India – 500032
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Gls Pharma Limited
Gls Pharma Limited has undergone 2 name changes throughout its history. The company was previously known as Gls Pharma Private Limited, and Getwell Life Sciences India Private Limited.. The current legal name is Gls Pharma Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Gls Pharma Limited | Current |
| Gls Pharma Private Limited | Previous |
| Getwell Life Sciences India Private Limited. | Previous |
CIN History of Gls Pharma Limited
Gls Pharma Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239TS2004PLC184306, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TS2004PLC184306 | Current |
| U24239DL2004PTC128728 | Previous |
| U24239DL2004PLC128728 | Previous |
Associated Brands with Gls Pharma Limited
Gls Pharma Limited operates one associated brand: GLS Pharma. These brands represent Gls Pharma Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Oncology APIs and anti-cancer products are manufactured. | glspharma.com |
Business Activity of Gls Pharma Limited
Gls Pharma Limited operates primarily in the manufacturing sector. The company has 2 registered business activity segments, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Locked | Manufacturing | Locked | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| Locked | Manufacturing | Locked | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Detailed business activity records for Gls Pharma Limited
Activity codes and turnover contribution percentages require an active report plan.
- Activity group codes
- Detailed activity codes
- Turnover contribution
Verified entity values are shown only after access is granted.
Auditor Details of Gls Pharma Limited
Gls Pharma Limited is audited by G P M & ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G P M & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for Gls Pharma Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Gls Pharma Limited
Gls Pharma Limited is currently managed by 3 directors, with 19 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Ramachandra Rao Ilapakurthy | Director | 15 Dec 2023 | 2 Years 8 Months | Current |
|
Pendem Harish Babu
Also directs:
Gls Pharma Limited, Auro Pharma Limited
|
Additional Director | 25 Oct 2025 | 0 Years 9 Months | Current |
|
Ravikiran Namburi
Also directs:
Gls Pharma Limited
|
Director | 20 Sep 2024 | 1 Years 10 Months | Current |
Financials of Gls Pharma Limited FY 2025 filings available
Gls Pharma Limited reported revenue of ₹36.08 Cr (up 13862.30% YoY) for FY 2023.
Ten-year financial statements for Gls Pharma Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Gls Pharma Limited
Shareholding and ownership data for Gls Pharma Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gls Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Sep 2022 | Canara Bank | ₹2 Cr | Open |
| 30 Aug 2021 | Canara Bank | ₹2.5 Cr | Satisfied |
| 15 Dec 2020 | Syndicate Bank | ₹96 Lakh | Satisfied |
| 14 Dec 2020 | Canara Bank | ₹80 Lakh | Satisfied |
| 30 Sep 2015 | Syndicate Bank | ₹7.97 Cr | Satisfied |
Total charge records: 8 View all charges
Employees and EPFO Compliance at Gls Pharma Limited
Gls Pharma Limited has a workforce of 116 employees as of Apr 03, 2024.
Employee and EPFO history for Gls Pharma Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Gls Pharma Limited
GST registrations and filing compliance for Gls Pharma Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Gls Pharma Limited
Credit ratings, litigation, and regulatory alerts for Gls Pharma Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gls Pharma Limited
MSME payment history for Gls Pharma Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gls Pharma Limited
Corporate group structure for Gls Pharma Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gls Pharma Limited
MCA filings and documents for Gls Pharma Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Gls Pharma Limited
Frequently Asked Questions about Gls Pharma Limited
Gls Pharma Limited is an active public limited company in the pharma sector based in Seri Lingampally, Telangana, India. It was incorporated on 01 September 2004 (22+ years old) and is registered under CIN U24239TS2004PLC184306. The company has 116 employees.
Gls Pharma Limited reported revenue of ₹36.08 Cr for FY 2023 (up 13862.30% YoY).
The current directors of Gls Pharma Limited are:
- Srinivasa Ramachandra Rao Ilapakurthy - Director
- Pendem Harish Babu - Additional Director
- Ravikiran Namburi - Director
The primary industry of Gls Pharma Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Gls Pharma Limited can be reached at the registered office: Galaxy Floors 22 – 24 Plot No. 1 Survey No. 831, Hyderabad Knowledge City Raidurg Panmaktha, Seri Lingampally, Telangana, India – 500032, or through the website glspharma.com.
The authorised capital is ₹1.3 Cr, and the paid-up capital is ₹1.2 Cr.